21 C.F.R. § 556.169

Danofloxacin.

Last amended: 2019Year: 2026Length: 54 wordsSubsections: 4Official source

Cite as 21 C.F.R. § 556.169 (2026)

(a) Acceptable daily intake (ADI). The ADI for total residue of danofloxacin is 2.4 µg/kg of body weight per day. (b) Tolerances. The tolerances for danofloxacin (marker residue) are: (1) Cattle. (i) Liver (target tissue): 0.2 ppm. (ii) Muscle: 0.2 ppm. (2) [Reserved] (c) Related conditions of use. See § 522.522 of this chapter.
Cross-references to the CFR
522.522
21 C.F.R. § 556.169: Danofloxacin. | Justis AI